4//SEC Filing
Brophy Gerard 4
Accession 0001722482-22-000061
CIK 0001722482other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 9:32 PM ET
Size
10.7 KB
Accession
0001722482-22-000061
Insider Transaction Report
Form 4
Avantor, Inc.AVTR
Brophy Gerard
EVP, Biopharma Production
Transactions
- Award
Stock Options (Right to Buy)
2022-02-23+43,708→ 43,708 totalExercise: $33.09Exp: 2032-02-23→ Common Stock (43,708 underlying) - Sale
Common Stock
2022-02-23$33.79/sh−3,059$103,364→ 125,181 total - Award
Common Stock
2022-02-23+15,110→ 140,291 total - Tax Payment
Common Stock
2022-02-25$35.39/sh−2,043$72,302→ 138,248 total
Footnotes (5)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $33.75 to $33.94 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth above.
- [F3]Reflects a grant of restricted stock units that vest in four equal annual installments beginning on February 23, 2023.
- [F4]Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSU's.
- [F5]Reflects a grant of stock options that vest in four equal annual installments beginning on February 23, 2023.
Documents
Issuer
Avantor, Inc.
CIK 0001722482
Entity typeother
Related Parties
1- filerCIK 0001776107
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 9:32 PM ET
- Size
- 10.7 KB